Image Ben Hargreaves Oncology The future is now: AI and more effective cancer screening Ben Hargreaves examines how AI cancer diagnosis is currently being implemented, and how it could evolve in the years ahead, including the potential for the exploration of digital biomarkers R&D Was the response to monkeypox a success? The viral disease that infected a number of people across various countries caused significant alarm for its potential to spread rapidly. Market Access What happened to all the antibiotics? Across the world, there are reports of shortages of common antibiotics. R&D Can genetic data be a magic bullet for drug R&D? Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Load more results
Oncology The future is now: AI and more effective cancer screening Ben Hargreaves examines how AI cancer diagnosis is currently being implemented, and how it could evolve in the years ahead, including the potential for the exploration of digital biomarkers
R&D Was the response to monkeypox a success? The viral disease that infected a number of people across various countries caused significant alarm for its potential to spread rapidly.
Market Access What happened to all the antibiotics? Across the world, there are reports of shortages of common antibiotics.
R&D Can genetic data be a magic bullet for drug R&D? Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments.
News AZ claims another win for Imfinzi in frontline liver cancer AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
